Increased detection of enterovirus A71 infections, Germany, 2019 by Böttcher, Sindy et al.
1www.eurosurveillance.org
Rapid communication
Increased detection of enterovirus A71 infections, 
Germany, 2019
Sindy Böttcher¹, Sabine Diedrich¹, Kathrin Keeren², the Laboratory Network for Enterovirus Diagnostic (LaNED)³
1. National Reference Centre for Poliomyelitis and Enteroviruses, Robert Koch Institute, Berlin, Germany
2. Secretary of the National Commission for Polio Eradication in Germany, Robert Koch Institute, Berlin, Germany
3. The members of the network are listed at the end of the article
Correspondence: Sindy Böttcher (BoettcherS@rki.de)
Citation style for this article: 
Böttcher Sindy, Diedrich Sabine, Keeren Kathrin, the Laboratory Network for Enterovirus Diagnostic (LaNED). Increased detection of enterovirus A71 infections, 
Germany, 2019. Euro Surveill. 2019;24(39):pii=1900556. https://doi.org/10.2807/1560-7917.ES.2019.24.39.1900556 
Article submitted on 05 Sep 2019 / accepted on 26 Sep 2019 / published on 26 Sep 2019
We report on the increased circulation of enterovirus 
A71 in Germany in 2019. Strains were mainly identi-
fied in hospitalised patients with suspected aseptic 
meningitis/encephalitis. Molecular analysis showed 
co-circulation of EV-A71 sub-genogroups C1 and C4, a 
signal for physicians and public health authorities to 
include/intensify EV diagnostic in patients showing 
signs of aseptic meningitis, encephalitis or acute flac-
cid paralysis/myelitis.
In Europe, enterovirus A71 (EV-A71) has mainly been 
detected sporadically in patients with neurological dis-
orders. C2 has been the predominant sub-genogroup 
during the last decade [1]. A multi-recombinant C1 line-
age (C1-like) emerged in 2015 in Germany [2-4]. Since 
then, it was detected in sporadic cases with severe 
neurological disease in several European countries 
[4-6], as well as in an outbreak in Catalonia, Spain in 
2016 [7,8]. In south-eastern Asia, EV-A71, sub-geno-
group C4 strains have been mainly associated with 
severe and even fatal courses of hand, foot and mouth 
disease (HFMD) in children [1].
Here we report on an increase of EV-A71 C1-like strains 
in Germany in 2019 and first detections of EV-A71 C4 
strains in patients with neurological disease and HFMD.
Enterovirus surveillance in Germany
In Germany, enterovirus surveillance (EVSurv) is 
conducted within the framework of the Global Polio 
Eradication Initiative and provides continuous data 
on circulating enteroviruses since 2006. Stool or cer-
ebrospinal fluid samples of hospitalised patients with 
signs of aseptic meningitis/encephalitis and/or acute 
flaccid paralysis are analysed within a quality-con-
trolled laboratory network (LaNED). Laboratory results 
and pseudonymised patient data are reported to the 
national public health institute (Robert Koch Institute; 
RKI). Data are analysed and the results are publically 
available at evsurv.rki.de. Previous data on EV-A71 
circulation suggested that EV-A71 strains circulate in 
upsurges every 3 years, with 2010 and 2013 being epi-
demic years in Germany [2].
Typing of enterovirus (EV) strains is performed accord-
ing to the individual network laboratory algorithm, by 
sequencing the complete or partial VP1 or VP4/VP2 
region and/or virus isolation and typing by neutralisa-
tion assay. Assignment of the EV-A71 strains to one of 
the seven known sub-genogroups was performed using 
the Enterovirus Genotyping Tool [9] and/or neighbour-
joining algorithm-based phylogenetic tree analysis. All 
sequences were submitted to GenBank under acces-
sion numbers (MN397830-MN397906).
Since 2006, ca 2,500 samples have been tested annu-
ally within the EVSurv for a total of ca 34,000 analysed 
since that time. Of these, 25–30% were EV-positive. 
Overall, echovirus 30 was the most prevalent EV 
type (n = 2,194), followed by echovirus 6 (n = 775) and 
EV-A71 (n = 496). A total of 32 EV-A71 positive samples 
were documented in 2017 and 40 in 2018.
Enterovirus A71 detections through 
enterovirus surveillance
From January 2019 to the end July 2019, 38 EV-A71 
positive patients were registered, including one fatal 
case. EV-A71-positive patients were observed in March 
(n = 2), April (n = 3), May (n = 6), June (n = 14) and July 
(n = 13). Besides EV-A71, CV-B5 was the second most 
common EV type (n = 24) within the EVSurv this year. 
Typing results are still pending for 35% (73/209) of 
EV-positive samples.
Of the 38 EV-A71 strains detected, 26 were analysed fur-
ther at the National Reference Centre for Poliomyelitis 
and Enteroviruses (NRZ PE). Sequencing of the VP1 
region was done as described previously [2]. Twenty-
one strains were assigned to C1-like, four to sub-geno-
group C4 and one to sub-genogroup C2 (Table 1).
2 www.eurosurveillance.org
Epidemiological data
EV-A71-positive samples were reported from 11 of 16 
federal states in Germany, with patients hospitalised 
in 20 different hospitals. All patients were between 0 
and 10 years old, with 30 of 38 between 0 and 5 years 
old. Of these, 8 were younger than 1 year old. Twenty-
one were male and 17 were female. All EV-A71 strains 
were detected in stool samples.
Phylogenetic relation
Sequence analysis of C1-like strains identified in 2019 
showed high nucleotide (nt) identities with recently 
detected strains, indicating a rapid widespread circula-
tion of this new recombinant variant [4]. Phylogenetic 
tree calculation showed several lineages either group-
ing separately or clustering to recent strains detected 
in France, Poland, Spain, Denmark, the United States 
(US) and Japan (Figure 1A).
Sequence analysis of sub-genogroup C4 showed 
separate clustering of the German EV-A71 C4 strains 
detected in 2011–2013 and 2018–July 2019. Currently-
circulating strains grouped together with EV-A71 C4 
strains detected in south-eastern Asia (Figure 1B) 
with highest nt identities to MH716155, MH716157 and 
MG431943 detected in patients with severe HFMD. This 
cluster also includes strains isolated from patients 
with severe HFMD and even fatal courses (KT428649, 
KT428650).
Enterovirus A71 detections in routine 
samples
The increased circulation of EV-A71 in 2019 has also 
been indicated by samples routinely sent to the NRZ PE, 
mostly from other laboratories sending in EV-positive 
samples for typing, but also from clinicians/hospitals 
not yet participating in EVSurv or those submitting 
samples from patients with diseases other than sus-
pected aseptic meningitis/encephalitis or acute flac-
cid paralysis/myelitis. Of 126 EV strains typed from 
January through July 2019, 23 were assigned to EV-A71. 
Of these, 19 were assigned to EV-A71 lineage C1-like, 
three to EV-A71 sub-genogroup C4 and one to EV-A71 
sub-genogroup C2 (Table 2). Notably, the number of 
EV-A71 detections in the first 7 months of 2019 (n = 23) 
has already exceeded the total of such detections for 
2017 and 2018, as well as the totals from the epidemic 
years of 2010 (6/61), 2013 (12/206) and 2016 (17/144).
Germany does not conduct standardised HFMD surveil-
lance, but occasionally, samples collected within nurs-
ery school outbreaks of HFMD are submitted to the 
NRZ PE by the local health authorities. From 2010 until 
2018, between 15 and 82 samples from HFMD patients 
were submitted per year, with 6 to 57 patients being 
positive for EV and 2 to 8 patients being positive for 
EV-A71 annually. In 2018, there were 24 HFMD patients 
positive for EV, eight of whom had EV-A71. Of those 
eight, EV-A71 C4 was detected for the first time in four 
children with HFMD. For two strains (17672, 17673), the 
VP1 region was sequenced and compared with EV-A71 
C4 strains identified in samples analysed within the 
EVSurv in 2018 and 2019. Close clustering indicates 
that there is no relationship between the VP1 region 
sequence and the presence of HFMD or symptoms 
related to aseptic meningitis/encephalitis (Figure 1B).
Discussion and conclusion
Our findings suggest an increased circulation of EV-A71 
strains in Germany already in the first 7 months of the 
year. Considering the fact that the EV season is still 
ongoing, the data available suggest that 2019 will 
become an epidemic year similar to 2016, 2013 and 
2010.
The emergence of new EV variants exhibiting altered 
antigenic sites might result in increased circulation and/
or changed clinical manifestation. In Europe, EV-A71 
was only sporadically associated with neurological dis-
ease during the past 30 years. In Germany, the predom-
inant EV-A71 sub-genogroup C2 was replaced by C1-like 
strains in 2016. Emergence of EV-A71 sub-genogroup 
C4 strains in Germany was detected between 2011 and 
2013 [2], with France [10], Russia [11] and Denmark [12] 
also reporting such detection around the same time.
One limitation of the EVSurv is that no detailed clinical 
information is available since the EVSurv request form 
deliberately only asks for basic cardinal symptoms: 
fever, nuchal rigidity, headache and vomiting. Since 
non-polio EV infections are not mandatorily notifiable 
at federal level in Germany, no data on severe cases or 
deaths are available. No routine testing for EV is per-
formed in deaths so we therefore cannot exclude fatal 
cases with other EV than EV-A71. Nevertheless, we were 
informed of an additional fatal case where EV-A71 was 
detected in a German child hospitalised in Austria in 
July 2019 (personal communication, Franz Allerberger 
Table 1
Number of enterovirus surveillance samples analysed and 















Total 2,444 2,188 1,959 1,160
EV-positive 527 448 416 209
EV-typed 445 380 349 136
EV-A71-positive 77 32 40 38
EV-A71 sub-genogroups
Lineage C1-like 57 18 23 21
C2 10 6 0 1
C4 0 0 12 4
ND 10 8 5 12
EV: enterovirus; EVSurv: enterovirus surveillance; Jan: January; Jul: 
July; ND: not determined.
Number of EV-A71 strains and sub-genogroup assignment based 
on the VP1 region is shown.
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Figure 1
Phylogenetic trees of (A) sub-genogroup C1, including lineage C1-like and (B) sub-genogroup C4, 2019































































































MH716157 China 2017 sHFMD
MH716155 China 2016 sHFMD
MG431943 China 2017 sHFMD
MG844031 Thailand 2017
MH716150 China 2015 sHFMD
MG756693 Taiwan 2015
KT428649 China 2014 fatal
KT428644 China 2014 sHFMD
KT428650 China 2014 fatal

















































The phylogenetic tree is based on complete viral protein 1 (VP1) nucleotide (nt) sequences (891 b corresponding to nt position 2439–3329 in 
the prototype BrCr ETU22521). Strains identified within the German enterovirus surveillance (EVSurv) and a representative set of enterovirus 
A71 strains retrievable from GenBank were used. Only sequences covering the complete VP1 region were included in the analysis. Subtrees 
including only EV-A71 sub-genogroup C1, including lineage C1-like (A) and EV-A71 sub-genogroup C4 (B) are shown. Strains identified within 
the EVSurv are marked with filled diamonds and strains identified in hand, foot and mouth disease (HFMD) patients with open diamonds. The 
tree was calculated using the neighbour-joining algorithm with 1,000 replicates in MEGA software version 7.0.26. Only bootstrap values > 70 
are shown. Scale bars indicate nt substitution per site.
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and Birgit Prochazka, August 2019). Taken together 
with the fatal case reported in the EVSurv, this raises 
concern about increased occurrence of severe cases as 
a consequence of increased EV-A71 circulation.
Reports of severe clinical presentation associated with 
detection of a EV-A71 C1-like strains [3,5-7], together 
with recent indications of long-term sequelae [13,14], 
should be a signal for physicians and public health 
authorities to include/intensify EV diagnostic in 
patients showing signs of aseptic meningitis, encepha-
litis or acute flaccid paralysis/myelitis.
Continued virological data could provide first hints 
to upcoming public health matters. (EV typing should 
be conducted to enable molecular epidemiology. 
Furthermore, systematic studies are needed to assess 
the burden of EV infections in Europe.
Laboratory Network for Enterovirus Diagnostic (LaNED)
Nikolaus Ackermann, Maja Adam, Armin Baillot, Ingrid 
Ehrhard, Martin Enders, Wali Hafezi, Ralph Hahn, Jörg 
Hofmann, Klaus Korn, Joachim Kühn, Detlef Michel, 
Alexandra Pettke, Christiane Prifert, Holger F. Rabenau, 
Ursula Reif, Gabriele Rieder, Benedikt Weißbrich, Andreas 
Wille and Marta J Zuchowski.
Acknowledgements
We thank all clinicians participating in the German entero-
virus surveillance; all cooperating labs sending enterovirus 
strains for typing; the local health authorities for collecting 
samples from hand, foot and mouth disease patients; and 
the technical staff in all labs for excellent performance.
Funding statement: Results were obtained during routine 





Members of the Laboratory Network (LaNED) analysed sam-
ples at the laboratory level. KK coordinated the EVSurv and 
collected the data. KK, SD and SB analysed the data. SB 
wrote the manuscript draft, all co-authors commented and 
approved the final version.
References
1. Hassel C, Mirand A, Lukashev A, TerletskaiaLadwig E, Farkas 
A, Schuffenecker I, et al. Transmission patterns of human 
enterovirus 71 to, from and among European countries, 2003 
to 2013. Euro Surveill. 2015;20(34):30005.  https://doi.
org/10.2807/1560-7917.ES.2015.20.34.30005  PMID: 26530407 
2. Böttcher S, Obermeier PE, Neubauer K, Diedrich SLaboratory 
Network for Enterovirus Diagnostics. Recombinant Enterovirus 
A71 Subgenogroup C1 Strains, Germany, 2015. Emerg 
Infect Dis. 2016;22(10):1843-6.  https://doi.org/10.3201/
eid2210.160357  PMID: 27439117 
3. Karrasch M, Fischer E, Scholten M, Sauerbrei A, Henke A, Renz 
DM, et al. A severe pediatric infection with a novel enterovirus 
A71 strain, Thuringia, Germany. J Clin Virol. 2016;84:90-5.  
https://doi.org/10.1016/j.jcv.2016.09.007  PMID: 27771495 
4. Ngangas ST, Lukashev A, Jugie G, Ivanova O, Mansuy 
JM, Mengelle C, et al. Multirecombinant Enterovirus A71 
Subgenogroup C1 Isolates Associated with Neurologic Disease, 
France, 2016-2017. Emerg Infect Dis. 2019;25(6):1204-8.  
https://doi.org/10.3201/eid2506.181460  PMID: 31107209 
5. Wieczorek M, Purzyńska M, Krzysztoszek A, Ciąćka A, Figas 
A, Szenborn L. Genetic characterization of enterovirus A71 
isolates from severe neurological cases in Poland. J Med Virol. 
2018;90(2):372-6.  https://doi.org/10.1002/jmv.24958  PMID: 
28960454 
6. Antona D, Kossorotoff M, Schuffenecker I, Mirand A, Leruez-
Ville M, Bassi C, et al. Severe paediatric conditions linked 
with EV-A71 and EV-D68, France, May to October 2016. Euro 
Surveill. 2016;21(46):30402.  https://doi.org/10.2807/1560-
7917.ES.2016.21.46.30402  PMID: 27918268 
7. Casas-Alba D, de Sevilla MF, Valero-Rello A, Fortuny C, García-
García JJ, Ortez C, et al. Outbreak of brainstem encephalitis 
associated with enterovirus-A71 in Catalonia, Spain (2016): a 
clinical observational study in a children’s reference centre in 
Catalonia. Clin Microbiol Infect. 2017;23(11):874-81.  https://
doi.org/10.1016/j.cmi.2017.03.016  PMID: 28344164 
8. González-Sanz R, Casas-Alba D, Launes C, Muñoz-Almagro C, 
Ruiz-García MM, Alonso M, et al. Molecular epidemiology of an 
enterovirus A71 outbreak associated with severe neurological 
disease, Spain, 2016. Euro Surveill. 2019;24(7):1800089.  
https://doi.org/10.2807/1560-7917.ES.2019.24.7.1800089  
PMID: 30782267 
9. Kroneman A, Vennema H, Deforche K, v d Avoort H, Peñaranda 
S, Oberste MS, et al. An automated genotyping tool for 
enteroviruses and noroviruses. J Clin Virol. 2011;51(2):121-5.  
https://doi.org/10.1016/j.jcv.2011.03.006  PMID: 21514213 
10. Schuffenecker I, Henquell C, Mirand A, Coste-Burel M, Marque-
Juillet S, Desbois D, et al. New introductions of enterovirus 
Table 2
Number of samples sent to the National Reference Centre for Poliomyelitis and Enteroviruses for enterovirus detection and 
typing, Germany, 2010–July 2019































Total 128 78 137 279 166 153 252 279 278 213
EV-positive 61 58 59 206 93 81 144 147 181 126
EV-A71 positive 6 1 7 12 2 12 17 6 7 23
EV-A71 sub-genogroup
C1 0 0 1 3 1 0 0 0 0 0
Lineage C1-like 0 0 0 0 0 7 9 2 7 19
C2 6 1 1 9 0 4 8 4 0 1
C4 0 0 5 0 1 1 0 0 0 3
EV: enterovirus; Jan: January; Jul: July; NRZ-PE: National Reference Centre for Poliomyelitis and Enteroviruses.
Number of EV-A71 strains and sub-genogroup assignment based on the VP1 region is shown.
5www.eurosurveillance.org
71 subgenogroup C4 strains, France, 2012. Emerg Infect Dis. 
2014;20(8):1343-6.  https://doi.org/10.3201/eid2008.131858  
PMID: 25061698 
11. Akhmadishina LV, Govorukhina MV, Kovalev EV, 
Nenadskaya SA, Ivanova OE, Lukashev AN. Enterovirus A71 
Meningoencephalitis Outbreak, Rostov-on-Don, Russia, 2013. 
Emerg Infect Dis. 2015;21(8):1440-3.  https://doi.org/10.3201/
eid2108.141084  PMID: 26196217 
12. Fischer TK, Nielsen AY, Sydenham TV, Andersen PH, Andersen 
B, Midgley SE. Emergence of enterovirus 71 C4a in Denmark, 
2009 to 2013. Euro Surveill. 2014;19(38):20911.  https://doi.
org/10.2807/1560-7917.ES2014.19.38.20911  PMID: 25306878 
13. Huang MC, Wang SM, Hsu YW, Lin HC, Chi CY, Liu CC. 
Long-term cognitive and motor deficits after enterovirus 
71 brainstem encephalitis in children. Pediatrics. 
2006;118(6):e1785-8.  https://doi.org/10.1542/peds.2006-1547  
PMID: 17116698 
14. Chang LY, Lin HY, Gau SS, Lu CY, Hsia SH, Huang YC, et al. 
Enterovirus A71 neurologic complications and long-term 
sequelae. J Biomed Sci. 2019;26(1):57.  https://doi.org/10.1186/
s12929-019-0552-7  PMID: 31395054
License, supplementary material and copyright
This is an open-access article distributed under the terms of 
the Creative Commons Attribution (CC BY 4.0) Licence. You 
may share and adapt the material, but must give appropriate
credit to the source, provide a link to the licence and indicate 
if changes were made. 
Any supplementary material referenced in the article can be 
found in the online version.
This article is copyright of the authors or their affiliated in-
stitutions, 2019.
